000 01317 a2200385 4500
005 20250517192143.0
264 0 _c20181024
008 201810s 0 0 eng d
022 _a1878-1780
024 7 _a10.1016/j.diabet.2017.11.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLeggio, M
245 0 0 _aLow-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk?
_h[electronic resource]
260 _bDiabetes & metabolism
_cJun 2018
300 _a217-225 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAspirin
_xadministration & dosage
650 0 4 _aCardiovascular Diseases
_xprevention & control
650 0 4 _aDiabetes Complications
_xprevention & control
650 0 4 _aFibrinolytic Agents
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aPrimary Prevention
650 0 4 _aRisk Factors
700 1 _aBendini, M G
700 1 _aCaldarone, E
700 1 _aLombardi, M
700 1 _aSeveri, P
700 1 _aD'Emidio, S
700 1 _aStavri, D C
700 1 _aArmeni, M
700 1 _aBravi, V
700 1 _aMazza, A
773 0 _tDiabetes & metabolism
_gvol. 44
_gno. 3
_gp. 217-225
856 4 0 _uhttps://doi.org/10.1016/j.diabet.2017.11.002
_zAvailable from publisher's website
999 _c27905835
_d27905835